Trial of new osteoporosis drug beginning
Friday, January 15, 2010 - 20:14
in Biology & Nature
Endocrinologists are launching a human trial of a new drug that their research indicates holds great promise for building bones weakened by osteoporosis. An experimental drug called parathyroid hormone-related protein is an anabolic agent that appears to be unique in its ability to stimulate bone formation without simultaneously increasing bone breakdown.